Skip to main content
Top
Published in: Pituitary 1/2008

01-03-2008

Aromatase cytochrome P450 enzyme expression in human pituitary

Authors: Pinar Kadioglu, Gokhan Oral, Muge Sayitoglu, Nevin Erensoy, Berna Senel, Nurperi Gazioglu, Aydin Sav, Gursel Cetin, Ugur Ozbek

Published in: Pituitary | Issue 1/2008

Login to get access

Abstract

Aromatase (P450AROM) converts testosterone to estrogen. This conversion could be important in normal physiology and estradiol-induced tumorigenesis in human pituitary. The objective of this study was to examine the expression of P450AROM in normal human pituitary and determine the gender difference. We examined aromatase expression in 19 normal human pituitary glands [13 males, 6 females, median age: 30 years (interquartile ranges, IQR: 23–63)] obtained from autopsy. We demonstrated aromatase gene expression levels by quantitative RT-PCR and aromatase protein with immunohistochemical staining in normal male and female human pituitary. Although median relative expression level of aromatase mRNA of male individuals [median ΔCt = 42.6 (IQR: 7.6–93.9)] was higher than the female individuals [median ΔCt = 3.9 (IQR:0–44.8)], we could not determine a significant gender difference in aromatase mRNA levels (p = 0.2). The difference between the aromatase protein density by immunohistochemistry was not significant between genders (p = 0.78). The aromatase levels were also not correlated with the age of the study subjects (p = 0.42 r = −0.21). The results indicate that aromatase enzyme is present in human pituitary. The amount and the density of the enzyme show a large variance among different individuals. Although higher mRNA expression was observed in male pituitary compared to female pituitary, there was no statistically significant difference for gender or age.
Literature
1.
go back to reference Harada N (1988) Cloning of a complete cDNA encoding human aromatase: Immunochemical identification and sequence analysis. Biochem Biophys Res Commun 156:725–732PubMedCrossRef Harada N (1988) Cloning of a complete cDNA encoding human aromatase: Immunochemical identification and sequence analysis. Biochem Biophys Res Commun 156:725–732PubMedCrossRef
2.
go back to reference Bagatell CJ, Dahl KD, Bremner WJ (1994) The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J Androl 15:15–21PubMed Bagatell CJ, Dahl KD, Bremner WJ (1994) The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol. J Androl 15:15–21PubMed
3.
go back to reference Means GD, Mahendroo MS, Corbin CJ et al (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264:19385–19391PubMed Means GD, Mahendroo MS, Corbin CJ et al (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264:19385–19391PubMed
4.
go back to reference Sheckter CB, Matsumoto AM, Bremner WJ (1989) Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. J Clin Endocrinol Metab 68:397–401PubMed Sheckter CB, Matsumoto AM, Bremner WJ (1989) Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. J Clin Endocrinol Metab 68:397–401PubMed
5.
go back to reference Abdelgadir SE, Resko JA, Ojeda SR, Lephart ED, McPhaul MJ, Roselli CE (1994) Androgen regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brain. Endocrinology 135:395–401PubMedCrossRef Abdelgadir SE, Resko JA, Ojeda SR, Lephart ED, McPhaul MJ, Roselli CE (1994) Androgen regulate aromatase cytochrome P450 messenger ribonucleic acid in rat brain. Endocrinology 135:395–401PubMedCrossRef
6.
go back to reference Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 26:331–345PubMedCrossRef Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 26:331–345PubMedCrossRef
7.
go back to reference Sasano H, Takahashi K, Satoh F, Nagura H, Harada N (1998) Aromatase in the human central nervous system. Clin Endocrinol (Oxf) 48:325–329CrossRef Sasano H, Takahashi K, Satoh F, Nagura H, Harada N (1998) Aromatase in the human central nervous system. Clin Endocrinol (Oxf) 48:325–329CrossRef
8.
go back to reference Xu RK, Wu XM, Di AK, Xu JN, Pang CS, Pang SF (2000) Pituitary prolactin-secreting tumor formation: recent developments. Biol Signals Recept 9:1–20PubMedCrossRef Xu RK, Wu XM, Di AK, Xu JN, Pang CS, Pang SF (2000) Pituitary prolactin-secreting tumor formation: recent developments. Biol Signals Recept 9:1–20PubMedCrossRef
9.
go back to reference Spady TJ, Harvell DME, Snyder MC, Pennington KL, McComb RD, Shull JD (1998) Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilies to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 124:95–103PubMedCrossRef Spady TJ, Harvell DME, Snyder MC, Pennington KL, McComb RD, Shull JD (1998) Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilies to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 124:95–103PubMedCrossRef
10.
go back to reference Gottesfeld Z, Liehr JG (1987) Chronic exposure to random restraint stress retards the development of estrogen-induced pituitary prolactinoma in rats. Neurosci Lett 80:44–48PubMedCrossRef Gottesfeld Z, Liehr JG (1987) Chronic exposure to random restraint stress retards the development of estrogen-induced pituitary prolactinoma in rats. Neurosci Lett 80:44–48PubMedCrossRef
11.
go back to reference Prager D, Braunstein GD (1995) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 24:1–14PubMed Prager D, Braunstein GD (1995) Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 24:1–14PubMed
12.
go back to reference Gooren LJ, Assies J, Asscheman H, de Slegte R, van Kessel H (1988) Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 66:444–446PubMed Gooren LJ, Assies J, Asscheman H, de Slegte R, van Kessel H (1988) Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 66:444–446PubMed
13.
go back to reference Prior JC, Cox TA, Fairholm D, Kosthashuk E, Nugent R (1987) Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab 64:391–394PubMed Prior JC, Cox TA, Fairholm D, Kosthashuk E, Nugent R (1987) Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab 64:391–394PubMed
14.
go back to reference Sodi R, Fikri R, Diver M, Ranganath L, Vora J (2005) Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature. Ann Clin Biochem 42(Pt 2):153–159PubMedCrossRef Sodi R, Fikri R, Diver M, Ranganath L, Vora J (2005) Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature. Ann Clin Biochem 42(Pt 2):153–159PubMedCrossRef
15.
go back to reference Gillam MP, Middler S, Freed DJ, Molitch M (2002) The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87:4447–4451PubMedCrossRef Gillam MP, Middler S, Freed DJ, Molitch M (2002) The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87:4447–4451PubMedCrossRef
16.
go back to reference Naftolin F, Ryan KJ, Davies IJ et al (1975) The formation of estrogen by central neuroendocrine tissues. Recent Prog Horm Res 31:295–319PubMed Naftolin F, Ryan KJ, Davies IJ et al (1975) The formation of estrogen by central neuroendocrine tissues. Recent Prog Horm Res 31:295–319PubMed
17.
go back to reference Flores F, Naftolin F, Ryan KJ, White RJ (1973) Estrogen formation by the isolated perfused Rhesus monkey brain. Science 180:1074–1075PubMedCrossRef Flores F, Naftolin F, Ryan KJ, White RJ (1973) Estrogen formation by the isolated perfused Rhesus monkey brain. Science 180:1074–1075PubMedCrossRef
18.
go back to reference Lieberburg I, McEwen BS (1977) Brain cell nuclear retention of metabolites, 5α dihydrotestosterone and estrodiol-17β, in adult rats. Endocrinology 100:588–597PubMed Lieberburg I, McEwen BS (1977) Brain cell nuclear retention of metabolites, 5α dihydrotestosterone and estrodiol-17β, in adult rats. Endocrinology 100:588–597PubMed
19.
go back to reference Carretero J, Vázquez G, Blanco E et al (1999) Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis. Cell Tissue Res 295:419–423PubMedCrossRef Carretero J, Vázquez G, Blanco E et al (1999) Immunohistochemical evidence of the presence of aromatase P450 in the rat hypophysis. Cell Tissue Res 295:419–423PubMedCrossRef
20.
go back to reference Carretero J, Vazques G, Rubio M et al (2003) Postnatal differentiation of the immunohistochemical expression of aromatase P450 in the rat pituitary gland. Histol Histopathol 18:419–423PubMed Carretero J, Vazques G, Rubio M et al (2003) Postnatal differentiation of the immunohistochemical expression of aromatase P450 in the rat pituitary gland. Histol Histopathol 18:419–423PubMed
21.
go back to reference Jakap RL, Horvath TL, Leranth C, Harada N, Naftolin F (1993) Aromatase immunoreactivity in the rat brain: gonadectomy-sensitive hypothalamic neurons and an unresponsive “limbic ring” of the lateral septum-bed nucleus-amgdala complex. Steroid Biochem Mol Biol 44:481–498CrossRef Jakap RL, Horvath TL, Leranth C, Harada N, Naftolin F (1993) Aromatase immunoreactivity in the rat brain: gonadectomy-sensitive hypothalamic neurons and an unresponsive “limbic ring” of the lateral septum-bed nucleus-amgdala complex. Steroid Biochem Mol Biol 44:481–498CrossRef
22.
go back to reference Carretero J, Burks DJ, Vazquez G et al (2002) Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 5:5–10PubMedCrossRef Carretero J, Burks DJ, Vazquez G et al (2002) Expression of aromatase P450 is increased in spontaneous prolactinomas of aged rats. Pituitary 5:5–10PubMedCrossRef
23.
go back to reference Miyamoto J, Matsumoto T, Shiina H, Inoue K, Takada I, Ito S, Itoh J, Minematsu T, Sato T, Yanase T, Nawata H, Osamura YR, Kato S (2007) The pituitary function of androgen receptor constitutes a glucocorticoid production circuit. Mol Cell Biol 27:4807–4814PubMedCrossRef Miyamoto J, Matsumoto T, Shiina H, Inoue K, Takada I, Ito S, Itoh J, Minematsu T, Sato T, Yanase T, Nawata H, Osamura YR, Kato S (2007) The pituitary function of androgen receptor constitutes a glucocorticoid production circuit. Mol Cell Biol 27:4807–4814PubMedCrossRef
24.
go back to reference West B, Dannies PS (1980) Effects of estrodiol on prolactin production and dihydroergocryptine-induced inhibition of prolactin production in primary cultures of rat pituitary cells. Endocrinology 106:1108–1113PubMed West B, Dannies PS (1980) Effects of estrodiol on prolactin production and dihydroergocryptine-induced inhibition of prolactin production in primary cultures of rat pituitary cells. Endocrinology 106:1108–1113PubMed
25.
go back to reference Magrini B, Ebiner JR, Burckhardt P, Felber JP (1976) Study in the relationship between plasma prolactin levels and androgen metabolism. J Clin Endocrinol Metab 43:944–947PubMedCrossRef Magrini B, Ebiner JR, Burckhardt P, Felber JP (1976) Study in the relationship between plasma prolactin levels and androgen metabolism. J Clin Endocrinol Metab 43:944–947PubMedCrossRef
Metadata
Title
Aromatase cytochrome P450 enzyme expression in human pituitary
Authors
Pinar Kadioglu
Gokhan Oral
Muge Sayitoglu
Nevin Erensoy
Berna Senel
Nurperi Gazioglu
Aydin Sav
Gursel Cetin
Ugur Ozbek
Publication date
01-03-2008
Publisher
Springer US
Published in
Pituitary / Issue 1/2008
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-007-0065-3

Other articles of this Issue 1/2008

Pituitary 1/2008 Go to the issue